164 related articles for article (PubMed ID: 8776186)
1. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
[TBL] [Abstract][Full Text] [Related]
2. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
3. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
[TBL] [Abstract][Full Text] [Related]
4. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
5. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes TE; Fagerhol MK; Venge P
Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851
[TBL] [Abstract][Full Text] [Related]
6. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
7. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
8. Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery.
Borowiec JW; Bozdayi M; Jaramillo A; Nilsson L; Venge P; Henze A
J Card Surg; 1997; 12(3):190-7. PubMed ID: 9395949
[TBL] [Abstract][Full Text] [Related]
9. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
10. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
11. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
[TBL] [Abstract][Full Text] [Related]
12. Specific complement inhibition with heparin-coated extracorporeal circuits.
te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
[TBL] [Abstract][Full Text] [Related]
13. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
Borowiec JW; Hagman L; Tötterman TH; Pekna M; Venge P; Thelin S
Scand J Thorac Cardiovasc Surg; 1995; 29(4):167-74. PubMed ID: 8789469
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
[TBL] [Abstract][Full Text] [Related]
15. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
[TBL] [Abstract][Full Text] [Related]
16. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
Bozdayi M; Borowiec J; Nilsson L; Venge P; Thelin S; Hansson HE
Artif Organs; 1996 Sep; 20(9):1008-16. PubMed ID: 8864022
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
Pekna M; Borowiec J; Fagerhol MK; Venge P; Thelin S
Scand J Thorac Cardiovasc Surg; 1994; 28(1):5-11. PubMed ID: 7939508
[TBL] [Abstract][Full Text] [Related]
18. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits.
Jansen PG; te Velthuis H; Huybregts RA; Paulus R; Bulder ER; van der Spoel HI; Bezemer PD; Slaats EH; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):829-34. PubMed ID: 7564452
[TBL] [Abstract][Full Text] [Related]
19. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
20. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]